A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
Completed · Phase 3
Conditions studied: Prostate Cancer
In brief
Participants who completed the FE200486 CS21 study (NCT00295750) could enter the FE200486 CS21A study. The study continued until all non-discontinued participants had received treatment for at least 5 years.
Key facts
- Study ID
- NCT00451958
- Run by
- Ferring Pharmaceuticals
- People needed
- 386
- Starts
- 2007-03-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2013-03-21
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- South Orange County Medical Research Center — Laguna Hills, California, United States
- Western Clinical Research — Torrance, California, United States
- Urology Associates Research — Englewood, Colorado, United States
- South Florida Medical Research — Aventura, Florida, United States
- Investigational Site — Ocala, Florida, United States
- Regional Urology — Shreveport, Louisiana, United States
- Lawrenceville Urology — Lawrenceville, New Jersey, United States
- Investigational Site — Carmel, New York, United States
- North Urology Research — Concord, North Carolina, United States
- Investigational Site — Greensboro, North Carolina, United States
- State College Urologic Association — State College, Pennsylvania, United States
- Urology San Antonio Research — San Antonio, Texas, United States
- Seattle Urology Research Center — Burien, Washington, United States
- Investigational Site — Kentville, Nova Scotia, Canada
- The Female/Male Health Centres — Barrie, Ontario, Canada
- Brantford Urology Research — Brantford, Ontario, Canada
- Burlington Professional Centre — Burlington, Ontario, Canada
- The Urology Research Centre — Burlington, Ontario, Canada
- Investigational Site — Newmarket, Ontario, Canada
- The Female/Male Health Centres — Oakville, Ontario, Canada
- Urology South Shore Research — Greenfields, Quebec, Canada
- Can-Med Clinical Research Inc — Victoria, Canada
- Urocentrum Brno — Brno, Czechia
- UROHELP - Bozetechova — Brno, Czechia
- Urology Centers Of Alabama — Homewood, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.